A new coelozoic Myxozoan species, Ceratomyxa tunisiensis n. sp., was found infecting the gallbladders of two carangid fish, Caranx rhonchus and Trachurus trachurus (Perciforme, Carangidae), from the Gulf of Gabès, on the southern coast of Tunisia. The parasite develops in spherical mono-, diplo-, or polysporic tropozoites in the gallbladder of the hosts. Mature spores are typical of the genus Ceratomyxa. They are transversely elongated and narrowly crescent-shaped with a slightly convex anterior and concave posterior, and measure 23 ± 0. 27 (20-25) μm width × 6 ± 0.26 (5-8) μm in length. Spore shell valves are symmetrical with rounded ends. Two spherical polar capsules situated on either side of the sutural line measure 2.2 μm (2.0-3.0) in diam. Periodical sampling of C. rhonchus and T. trachurus from Marsh 2012 to February 2013 showed that infection due to C. tunisiensis occurs in 59% and 69% of the examined fish, respectively. Molecular analysis based on the small subunit (SSU) rRNA sequence shows high genetic divergence with all other ceratomyxid species. A Maximum Likelihood phylogenetic tree shows association with the species C. leatharjecketi Fiala, kova, Kodadkova, Freeman, Bartošova-Sojkova, and Atkinson, 2015 reported from the gallbladder of Aluterusmonoceros (L.) caught in the Andaman Sea, off Malaysia. Nonetheless, the SSU rRNA sequences of C. tunisiensis and C. leatharjecketi have only a 90% similarity.
Transdermal drug delivery systems (TDDSs) have become innovative, fascinating drug delivery methods intended for skin application to achieve systemic effects. TDDSs overcome the drawbacks associated with oral and parenteral routes of drug administration. The current investigation aimed to design, evaluate and optimize methotrexate (MTX)-loaded transdermal-type patches having ethyl cellulose (EC) and hydroxypropyl methyl cellulose (HPMC) at different concentrations for the local management of psoriasis. In vitro release and ex vivo permeation studies were carried out for the formulated patches. Various formulations (F1-F9) were developed using different concentrations of HPMC and EC. The F1 formulation having a 1:1 polymer concentration ratio served as the control formulation. ATR-FTIR analysis was performed to study drug-polymer interactions, and it was found that the drug and polymers were compatible with each other. The formulated patches were further investigated for their physicochemical parameters, in vitro release and ex vivo diffusion characteristics. Different parameters, such as surface pH, physical appearance, thickness, weight uniformity, percent moisture absorption, percent moisture loss, folding endurance, skin irritation, stability and drug content uniformity, were studied. From the hydrophilic mixture, it was observed that viscosity has a direct influence on drug release. Among all formulated patches, the F5 formulation exhibited 82.71% drug release in a sustained-release fashion and followed an anomalous non-Fickian diffusion. The permeation data of the F5 formulation exhibited about a 36.55% cumulative amount of percent drug permeated. The skin showed high retention for the F5 formulation (15.1%). The stability study indicated that all prepared formulations had very good stability for a period of 180 days. Therefore, it was concluded from the present study that methotrexate-loaded transdermal patches with EC and HPMC as polymers at different concentrations suit TDDSs ideally and improve patient compliance for the local management of psoriasis.